This federal contract award, with ID SPE2DB20D2002|SPE2DB25FL10X, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of loteprednol etabonate 0.2% eye drops, a pharmaceutical product, with an ultimate completion date of December 31, 2024 and a ceiling value of $1,122.87. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a Set-Aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/31/25, 9:40 AM